Cellomics Inc.

Main Activity in Nanotechnology
Material Manufacturer
About Company
Cellomics, a business unit within the Fisher Biosciences group, provides complete systems for High Content Screening (HCS) and Analysis (HCA) to drug discovery and systems biology researchers. The Cellomics platform includes automated imaging instrumentation (ArrayScan® and KineticScan® HCS Readers), BioApplication image analysis software, High Content Informatics (HCi™), and HitKit® HCS Reagent Kits, fully integrated to improve the quality and productivity of cell-based assays. Cellomics’ proprietary platforms are in use at multiple sites within the top 15 pharmaceutical companies, as well as leading biotechnology companies and academic centers throughout the world.
Cellomics Inc.100 Technology Drive |
Share with friends:
Nanotechnology in medicine | Nano materials | Nanotechnology electronics | Nano asociation |
Follow Nanotechnology Journal on
© 2008 - 2019 Nanotechnology research | All rights reserved | Developed by Makovic.net